An FDA Committee Just Voted in Favor of Peptides—Despite the Agency's Opposition
Food and Drug Administration (FDA) committee voted against FDA staff’s own advice in a meeting on July 23, recommending that two peptides, called BP-157 and KPV, be added to a list that will allow certain specialty pharmacies to dispense them. Currently, those peptides—and the other five being considered—are in a legal gray area. Here’s what to know.What are peptides?Peptides are short chains of amino acids, which are the building blocks of proteins.
- ▪Food and Drug Administration (FDA) committee voted against FDA staff’s own advice in a meeting on July 23, recommending that two peptides, called BP-157 and KPV, be added to a list that will allow certain specialty pharmacies to dispense th
- ▪Currently, those peptides—and the other five being considered—are in a legal gray area.
- ▪Here’s what to know.What are peptides?Peptides are short chains of amino acids, which are the building blocks of proteins.
Opening excerpt (first ~120 words) tap to expand
In a highly unusual move, a U.S. Food and Drug Administration (FDA) committee voted against FDA staff’s own advice in a meeting on July 23, recommending that two peptides, called BP-157 and KPV, be added to a list that will allow certain specialty pharmacies to dispense them. Currently, those peptides—and the other five being considered—are in a legal gray area. Here’s what to know.What are peptides?Peptides are short chains of amino acids, which are the building blocks of proteins. Peptide concoctions have grown in popularity over the past several years as injectable substances that proponents claim improve energy, sleep, sex drive, and more. U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has supported reclassifying peptides to improve people’s access to them.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at TIME — Top.
Discussion
0 commentsMore from TIME — Top
